Stifel Maintains Buy on Zimmer Biomet Holdings, Raises Price Target to $140

Benzinga · 1d ago
Stifel analyst Rick Wise maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Buy and raises the price target from $125 to $140.